Latest receivables for PLSE: $160K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Pulse Biosciences (PLSE) currently reports a receivables of $160K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Pulse Biosciences's receivables history and peer comparisons.
Pulse Biosciences's receivables changed from $0 to $160K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Pulse Biosciences reported $160K in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $160K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pulse Biosciences, and consider following PLSE for alerts when major investors trade the stock.
Pulse Biosciences is classified in the Healthcare sector. On receivables, it currently shows $160K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLSE with unrelated industries.